Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
Saed Abbasi,
No information about this author
Miki Matsui-Masai,
No information about this author
Fumihiko Yasui
No information about this author
et al.
Molecular Therapy,
Journal Year:
2024,
Volume and Issue:
32(5), P. 1266 - 1283
Published: April 2, 2024
Carrier-free
naked
mRNA
vaccines
may
reduce
the
reactogenicity
associated
with
delivery
carriers;
however,
their
effectiveness
against
infectious
diseases
has
been
suboptimal.
To
boost
efficacy,
we
targeted
skin
layer
rich
in
antigen-presenting
cells
(APCs)
and
utilized
a
jet
injector.
The
injection
efficiently
introduced
into
cells,
including
APCs
mice.
Further
analyses
indicated
that
APCs,
after
taking
up
antigen
skin,
migrated
to
lymph
nodes
(LNs)
for
presentation.
Additionally,
provoked
localized
lymphocyte
infiltration
serving
as
physical
adjuvant
vaccination.
Without
carrier,
our
approach
confined
distribution
site,
preventing
systemic
leakage
proinflammatory
reactions.
In
mouse
vaccination,
elicited
robust
antigen-specific
antibody
production
over
6
months,
along
germinal
center
formation
LNs
induction
of
both
CD4-
CD8-positive
T
cells.
By
targeting
SARS-CoV-2
spike
protein,
this
provided
protection
viral
challenge.
Furthermore,
generated
neutralizing
antibodies
non-human
primates
at
levels
comparable
those
observed
conclusion,
offers
safe
effective
option
diseases.
Language: Английский
Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
D. N. Kisakov,
No information about this author
Л. И. Карпенко,
No information about this author
L. A. Kisakova
No information about this author
et al.
Vaccines,
Journal Year:
2025,
Volume and Issue:
13(1), P. 65 - 65
Published: Jan. 13, 2025
Background:
Although
mRNA
vaccines
encapsulated
in
lipid
nanoparticles
(LNPs)
have
demonstrated
a
safety
profile
with
minimal
serious
adverse
events
clinical
trials,
there
is
opportunity
to
further
reduce
reactogenicity.
The
development
of
naked
could
improve
vaccine
tolerability.
Naked
nucleic
acid
delivery
using
the
jet
injection
method
may
be
solution.
Methods:
In
first
part
study,
optimal
conditions
providing
low
traumatization
and
high
expression
model
mRNA-GFP
molecule
tissues
laboratory
animals
were
determined.
Then,
we
used
selected
protocol
immunize
BALB/c
mice
mRNA-RBD
encoding
SARS-CoV-2
receptor-binding
domain
(RBD).
It
was
that
vaccinated
developed
level
specific
antibodies
virus-neutralizing
activity.
also
induced
strong
RBD-specific
T-cell
response
reduced
viral
load
lungs
after
infection
virus.
immune
immunized
spring-loaded
injector
comparable
LNPs.
Results:
this
efficacy
an
inexpensive,
simple,
safe
evaluated
validated.
Conclusions:
Our
findings
suggest
possible
alternative
LNPs
for
delivering
against
infection.
Language: Английский
Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats
Cenrong Wang,
No information about this author
Xin Tang,
No information about this author
Chenghan Jiang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 17, 2025
Introduction
Needle-free
injection
system
(NFIS)
is
easy
to
operate
and
can
decrease
needle
phobia.
Besides,
NFIS
increase
the
interaction
of
antigens
in
a
more
dispersed
manner
with
immune
cell
at
local
site,
which
may
improve
responses
mRNA
vaccines.
Although
SARS-CoV-2
vaccines
have
great
success,
universal
are
urgently
needed.
Delivering
by
preferred
combat
COVID-19.
Methods
RBD3-Fc
expressing
BA.4,
Delta,
prototype
RBD,
human
IgG
Fc
YTE
mutation
was
designed
synthesized.
The
safety
naked
mRNA-LNP
delivered
intradermally
using
(named
GV-01)
intramuscularly
via
needles
were
evaluated
compared
rats.
Results
prime-boost
regimen
administered
two
routes
resulted
potent
intradermal
delivery
displays
comparable
or
better
performance
terms
binding
antibodies,
neutralizing
antibodies
T
responses.
Naked
functional,
but
less
effective
than
Discussion
above
results
suggest
that
safe
immunogenic
be
used
as
an
alternative
needles/syringes
for
inoculation
elicit
robust
systematic
Language: Английский
Exploring the anti-anaphylaxis potential of natural products: A Review
Ahmed Salem Eid,
No information about this author
Eman M. Zaki,
No information about this author
Manal M. Sabry
No information about this author
et al.
Inflammopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 19, 2025
Abstract
Allergies
are
a
common
health
issue
affecting
many
people
around
the
world,
especially
in
developed
countries.
They
occur
when
immune
system
overreacts
to
substances
that
usually
harmless.
Some
allergic
conditions
include
asthma,
sinus
infections,
skin
rashes,
food
allergies,
hay
fever,
severe
reactions,
eczema,
swelling,
and
reactions
medications
or
insect
stings.
The
causes
of
these
allergies
complex
often
linked
genetics,
which
can
lead
heightened
responses
known
as
atopy.
Throughout
history,
plant
extracts
have
been
used
for
various
purposes,
including
medicine
food.
In
addition,
their
bioactive
compounds
show
wide
range
beneficial
effects,
such
reducing
fighting
oxidative
stress,
mast
cell
stabilizers,
lowering
inflammation,
highlighting
potential
treating
conditions.
Flavonoids
phenolic
commonly
anaphylaxis
potent
anti-inflammatory
action.
This
review
aims
promote
use
natural
products
treatments
anaphylaxis.
discovery
new
drugs
derived
from
sources
holds
significant
promise
management
Language: Английский
Clinical Translation Challenges and Strategies for Tumour Vaccines Considering Multiple Delivery Routes
Renjie Song,
No information about this author
Xiao Li,
No information about this author
Junsong Zhu
No information about this author
et al.
Vaccines,
Journal Year:
2025,
Volume and Issue:
13(5), P. 469 - 469
Published: April 27, 2025
Background:
The
high
incidence
and
mortality
rates
of
cancer
have
kept
it
at
the
top
research
agenda
for
global
healthcare
industry,
as
well
put
serious
economic
pressure
on
families
society.
It
has
gradually
been
recognised
that
reducing
through
various
interventions
combining
prevention
treatment
are
key
to
alleviating
burden
cancer.
Methods:
Retrieve
summarize
literature
related
delivery
methods
tumor
vaccines,
investigate
whether
these
applied
clinically
or
used
in
clinical
trials.
Results:
there
a
variety
vaccine
development,
but
only
very
small
number
studies
able
make
strides
towards
implementing
clinic,
which
is
closely
linked
drawbacks
with
means
delivery.
Conclusions:
This
review
analyses
reasons
why
difficult
apply
clinic
from
point
view
method
rather
than
design
vaccine.
also
describes
some
not
yet
vaccines
and,
considering
this
conjunction
those
currently
purpose,
predicts
their
prospects
future
application.
Language: Английский
Intradermal Injection of a Protein Alone Without Additional Adjuvants Using a Needle-Free Pyro-Drive Jet Injector Induces Potent CD8+ T Cell-Mediated Antitumor Immunity
Jukito Sonoda,
No information about this author
Izuru Mizoguchi,
No information about this author
Natsuki Yamaguchi
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 4442 - 4442
Published: May 7, 2025
Vaccines
usually
contain
an
adjuvant
that
activates
innate
immunity
to
promote
the
acquisition
of
adaptive
immunity.
Aluminum
and
lipid
nanoparticles
have
been
used
for
this
purpose,
but
their
accumulation
or
widespread
circulation
in
body
can
lead
adverse
effects.
In
contrast,
physical
adjuvants,
which
use
energy
transiently
stress
tissues,
do
not
persist
exposed
tissues
cause
lasting
Herein,
we
investigate
effects
intradermal
injection
endotoxin-free
ovalbumin
(OVA)
protein
alone
without
additional
adjuvants
using
a
needle-free
pyro-drive
jet
injector
(PJI)
on
tumor
vaccination
efficacy.
Intradermal
OVA
PJI
significantly
increased
OVA-specific
CD8+
T
cell
expansion
lymph
node,
although
node
swelling
was
much
less
than
when
aluminum
hydroxide
used.
The
also
induced
killing
activity
antibody
production
showed
strong
cell-dependent
prophylactic
antitumor
against
transplanted
E.G7-OVA
tumors.
particular,
fluorescent
enhanced
its
uptake
by
XCR1+
dendritic
cells,
ability
cross-present
extracellular
proteins
skin
draining
nodes.
addition,
expression
HMGB1,
one
potent
danger
signals
whose
has
reported
increase
response
shear
stress.
Thus,
any
induces
cell-mediated
enhancing
into
high
cross-presentation
capacity
accompanied
stress-induced
HMGB1.
Language: Английский
DNA Vaccine Encoding a Modified Hemagglutinin Trimer of Avian Influenza A Virus H5N8 Protects Mice from Viral Challenge
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(5), P. 538 - 538
Published: May 14, 2024
The
development
of
a
safe
and
effective
vaccine
against
avian
influenza
A
virus
(AIV)
H5N8
is
relevant
due
to
the
widespread
distribution
this
in
bird
population
existing
potential
risk
human
infection,
which
can
lead
significant
public
health
concerns.
Here,
we
developed
an
experimental
pVAX-H5
DNA
encoding
modified
trimer
AIV
hemagglutinin.
Immunization
BALB/c
mice
with
using
jet
injection
elicited
high
titer
antibody
response
(the
average
ELISA
was
1
×
105),
generated
level
neutralizing
antibodies
T-cell
response,
as
determined
by
ELISpot
analysis.
Both
liquid
lyophilized
forms
provided
100%
protection
immunized
lethal
challenge
A/turkey/Stavropol/320-01/2020
(H5N8).
results
obtained
indicate
that
has
good
opportunities
candidate
Language: Английский
Jet injection potentiates naked mRNA SARS-CoV-2 vaccine in mice and non-human primates by adding physical stress to the skin
Saed Abbasi,
No information about this author
Miki Matsui-Masai,
No information about this author
Fumihiko Yasui
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Feb. 27, 2023
Abstract
Naked
mRNA-based
vaccines
may
reduce
the
reactogenicity
associated
with
delivery
carriers,
but
their
effectiveness
has
been
suboptimal
against
infectious
diseases.
Herein,
we
aimed
to
enhance
efficacy
by
using
a
pyro-drive
liquid
jet
injector
that
precisely
controls
pressure
widely
disperse
mRNA
solution
in
skin.
The
injection
boosted
naked
efficiency
mouse
Mechanistic
analyses
indicate
dendritic
cells,
upon
uptake
of
antigen
skin,
migrate
draining
lymph
nodes
for
presentation.
Additionally,
activated
innate
immune
responses
presumably
inducing
physical
stress,
thus
serving
as
adjuvant.
From
safety
perspective,
our
approach,
utilizing
mRNA,
restricted
distribution
solely
site,
preventing
systemic
pro-inflammatory
reactions
following
vaccination.
Ultimately,
encoding
SARS-CoV-2
spike
protein
elicited
robust
humoral
and
cellular
immunity,
providing
protection
infection
mice.
Furthermore,
approach
induced
plasma
activity
neutralizing
non-human
primates,
comparable
observed
mice,
no
detectable
reactogenicity.
Language: Английский
State-of-the-Art Cancer Immunotherapies
Hisashi Nagase,
No information about this author
Takuma Kato,
No information about this author
Takayuki Yoshimoto
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(5), P. 2532 - 2532
Published: Feb. 22, 2024
Cancer
immunotherapy
is
a
type
of
cancer
therapy
utilizing
the
immune
system
to
fight
against
tumors
[...]
Language: Английский